We have observed
11 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
EMBEDDING NANOPARTICLES IN THERMOPLASTIC POLYMERS
MEMBRANE-ADHERENT SELF-ASSEMBLED SYSTEMS FOR TREATMENT OF OCULAR DISORDERS
A NUTRITIONAL SUPPLEMENT COMPOSITION SUITABLE FOR IMPROVING LEAN TISSUE MASS STATUS IN AN ADULT HUMAN
METHOD FOR TREATING RADIOTHERAPY-AND-CHEMOTHERAPY ASSOCIATED COGNITIVE OR EMOTIONAL IMPAIRMENT WITH CANNABINOIDS
METHODS AND BIOCOMPATIBLE COMPOSITIONS TO ACHIEVE SUSTAINED DRUG RELEASE IN THE EYE
RECOMBINANT BORRELIA PROTEINS AND METHODS OF USE THEREOF
APPARATUS AND PROCESSES FOR EXTRACTING AND DISTRIBUTING READY TO DRINK BEVERAGES
A METHOD FOR THE ENZYMATIC CONVERSION OF A PHENOL SUBSTRATE INTO A CORRESPONDING CATECHOL PRODUCT
SHAPED ELASTOMERIC CONTAINER WITH INTEGRATED LEAK RESISTANT SEAL
SHAPE MEMORY SILK MATERIALS
METHODS AND COMPOSITIONS FOR INJECTING HIGH CONCENTRATION AND/OR HIGH VISCOSITY ACTIVE AGENT SOLUTIONS